Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 06 2024 - 4:01PM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that
management will participate in a fireside chat at the Guggenheim
Healthcare Talks 6th Annual Biotechnology Conference on Wednesday,
February 7, 2024 at 9:00 a.m. ET.
A webcast of the presentation will be available on the "Events
& Presentations" of the "Investors & Media" section of the
Celldex website. A replay will be available for 30 days following
the event.
About Celldex Therapeutics, Inc.Celldex is a
clinical stage biotechnology company leading the science at the
intersection of mast cell biology and the development of
transformative therapeutics for patients. Our pipeline includes
antibody-based therapeutics which have the ability to engage the
human immune system and/or directly affect critical pathways to
improve the lives of patients with severe inflammatory, allergic
and autoimmune and other devastating diseases. Visit
www.celldex.com.
Company ContactSarah CavanaughSenior Vice
President, Corporate Affairs & Administration(508)
864-8337scavanaugh@celldex.com
Patrick TillMeru Advisors(484)
788-8560ptill@meruadvisors.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024
